The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase-dependent mechanism

  • Auteurs / Authors: Jeannot V, Busser B, Brambilla E, Wislez M, Robin B, Cadranel J, Coll JL, Hurbin A
  • Journal / Conference: International Journal of Cancer
  • Année / Year: 2013
  • PMID:  24374738
  • Lien vers la publication: https://www.ncbi.nlm.nih.gov/pubmed/24374738